2023
DOI: 10.1016/s2666-6367(23)00333-0
|View full text |Cite
|
Sign up to set email alerts
|

Cytopenias, Myelodysplastic Syndromes and Acute Myeloid Leukemia Following Approved Chimeric Antigen Receptor (CAR) T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles